Global Malaria Diagnostics Market is Expected to Foresee Significant Growth During the Forecast Period. North America to Witness the Highest Growth

The global malaria diagnostic market is expected to grow significantly by 2027 expanding at a reasonable CAGR of around 5% during the forecast period (2021-2027F). Malaria is a tropical life-threatening disease caused by the plasmodium parasite by the bite of the female anopheles mosquito. There are mainly five species of plasmodium that causes malaria in humans such as Plasmodium vivax, Plasmodium falciparum, Plasmodium malariae, Plasmodium ovale, and Plasmodium knowlesi.

For a detailed analysis of the Malaria diagnostics browse through https://univdatos.com/report/malaria-diagnostics-market/

The rapid advancement in technology and the rising demand for molecular-based diagnostics drive the market for malaria diagnosis. Furthermore, the continuously surging malaria cases and the fatalities considerably drive the market for malaria diagnosis. As per WHO, In 2020, there were an estimated 241 million cases of malaria worldwide and the estimated number of malaria deaths stood at 6,27,000 in 2020. The population groups such as infants, children under 5 years of age, pregnant women, and patients with HIV as well as people with low immunity, are at considerably higher risk of contracting malaria. Furthermore, the increasing awareness about the severity of the disease along with the government efforts contributes to the market for the malaria diagnostic.

For a detailed analysis browse through https://univdatos.com/get-a-free-sample-form-php/?product_id=21597

Based on technology, the market is segmented into rapid diagnostic tests (RDTs), PCR, microscopy, ELISA, and others. In 2020, the RDT segment held a significant share in the market owing to its cost efficiency, stability at higher temperatures and the provides results in a short duration. However, during the forecast period, the PCR segment is expected to witness considerable growth. This is mainly due to the increased efficiency and accuracy that can detect the specific strains of the malarial parasite. Furthermore, the increasing research on molecular diagnostic techniques is likely to have a positive impact on the segment growth in the malaria diagnostic market.

Based on end-users, the market is segmented into hospitals, clinics, and diagnostics laboratories. The hospital segment grabbed significant market share in the malaria diagnostics market in 2020. This is mainly due to the rapidly increasing hospitalization cases due to malaria. Furthermore, the increasing geriatric population and rising prevalence of multiple diseases along with malaria among them make hospitals ideal places for them to treat multiple diseases under a single roof.

Request for Sample of the report browse through https://univdatos.com/get-a-free-sample-form-php/?product_id=21597

For a better understanding of the market adoption of the malaria diagnostics, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada), Europe (Germany, France, Italy, Spain, United Kingdom, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of APAC), Latin America, Middle East & Africa (LAMEA). In 2020, the LAMEA accounted for growth in the global malaria diagnostic market during the forecast period. This is due to the increasing prevalence of malaria in the region. According to WHO, in past years the African region shouldered more than 90% of the malaria cases.

Access Bio., Inc., Abbott Laboratories, Premier Medical Corporation Pvt. Ltd., Sysmex Partec GmbH, bioMérieux, Beckman Coulter, Inc., Siemens Healthineers, Leica Microsystems GmbH, Nikon Corporation, and Olympus Corporation are some of the key players operating in the global Malaria diagnostics market. Several M&As along with partnerships have been undertaken by these players to develop various types of Malaria diagnostics devices.

Global Malaria Diagnostics Market Segmentation

Market Insight, by Technology

Market Insight, by End-users

Market Insight, by Region

• North America
  • United States
  • Canada
• Europe
  • France
  • Germany
  • Italy
  • Spain
  • United Kingdom
  • Rest of Europe
• Asia-Pacific
  • China
  • India
  • Japan
  • Rest of Asia-Pacific
• Latin America, the Middle East, and Africa
  • Brazil
  • Mexico
  • Rest of LAMEA

Top Company Profiles

• Access Bio. Inc.
• Abbott Laboratories
• Premier Medical Corporation Pvt. Ltd.
• Sysmex Partec GmbH
• bioMérieux
• Beckman Coulter Inc.
• Siemens Healthineers
• Leica Microsystems GmbH
• Nikon Corporation
• Olympus Corporation